Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

NCT00010452 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Iowa